Jeffrey Tate - Chief Operating Officer, Director at Cyclo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer, Director
Stock Symbol
CYTH, CYTHW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey Tate since 11/21/2023

Holdings reported by Jeffrey Tate for Cyclo Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 92K $65.3K $0.71 Oct 20, 2023 Direct
Warrant to Purchase Common Stock 32.9K $4.12K $0.13 Oct 20, 2023 Direct Common Stock
Stock Option (Right to Buy) 111K Jun 3, 2024 Direct Common Stock

Transactions reported by Jeffrey Tate for Cyclo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.